- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02966535
The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial
March 12, 2019 updated by: Won Ho Kim, MD, Seoul National University Hospital
Gas exchange disturbance frequently occurs in steep Trendelenburg position during robot-assisted laparoscopic prostatectomy or cystectomy.
Due to increased intrathoracic pressure and absorbed carbon dioxide (CO2) gas insufflated into abdominal cavity, hypercapnia as well as hypoxia may occur.
Inverse ratio ventilation or prolonged inspiratory time during mechanical ventilation has been reported to be improve gas exchange in adult respiratory distress syndrome.
The investigators attempt to test the hypothesis that prolonged inspiratory time may improve the gas exchange during robot-assisted laparoscopic urologic surgery.
Study Overview
Status
Completed
Conditions
Detailed Description
Gas exchange disturbance frequently occurs in steep Trendelenburg position during robot-assisted laparoscopic prostatectomy or cystectomy.
Due to increased intrathoracic pressure and absorbed CO2 gas insufflated into abdominal cavity, hypercapnia as well as hypoxia may occur.
Inverse ratio ventilation or prolonged inspiratory time during mechanical ventilation has been reported to be improve gas exchange in adult respiratory distress syndrome.
The investigators attempt to test the hypothesis that prolonged inspiratory time (I:E ratio = 1:1) may improve the gas exchange during robot-assisted laparoscopic urologic surgery.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 03080
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- American Society of Anesthesiologists physical status class I-II and scheduled for an elective robot-assisted laparoscopic radical prostatectomy or robot-assisted laparoscopic radical cystectomy
- Patients who voluntarily decides to participate in the trial and has agreed in written informed consent
Exclusion Criteria:
- Patients with the anatomical abnormalities of respiratory system(abnormal airway anatomy, severe scoliosis, post-pneumonectomy state), severe chronic respiratory diseases, chronic obstructive pulmonary disease (COPD), asthma, heart failure, obesity ( Body Mass Index [BMI] > 30kg/m2), severe hepatic failure or renal failure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1:2, 1:1 group
Inspiratory to expiratory time ratio (I:E ratio) of 1:2 during the first one hour of laparoscopy and then switched to I:E ratio of 1:1 during the rest time of laparoscopy.
|
Adjustment of Mechanical Ventilator Inspiratory to expiratory time ratio (1:2 to 1:1)
|
|
Active Comparator: 1:1, 1:2 group
Inspiratory to expiratory time ratio (I:E ratio) of 1:1 during the first one hour of laparoscopy and then switched to I:E ratio of 1:2 during the rest time of laparoscopy.
|
Adjustment of Mechanical Ventilator Inspiratory to expiratory time ratio (1:1 to 1:2)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PaCO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
PaCO2 (arterial partial pressure of carbon dioxide)
|
60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PaCO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 5 minutes after anesthesia induction
|
PaCO2 (arterial partial pressure of carbon dioxide)
|
5 minutes after anesthesia induction
|
|
PaO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 5 minutes after anesthesia induction
|
PaO2 (arterial partial pressure of oxygen)
|
5 minutes after anesthesia induction
|
|
PaO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 60 minutes after anesthesia induction
|
PaO2 (arterial partial pressure of oxygen)
|
60 minutes after anesthesia induction
|
|
PaCO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 120 minutes after anesthesia induction
|
PaCO2 (arterial partial pressure of carbon dioxide)
|
120 minutes after anesthesia induction
|
|
PaO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
PaO2 (arterial partial pressure of oxygen)
|
120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
PaCO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 10 min after restoration of supine position
|
PaCO2 (arterial partial pressure of carbon dioxide)
|
10 min after restoration of supine position
|
|
PaO2 (mmHg) in the patient's arterial blood gas analysis
Time Frame: 10 min after restoration of supine position
|
PaO2 (arterial partial pressure of oxygen)
|
10 min after restoration of supine position
|
|
Respiratory compliance (Static, Dynamic)
Time Frame: 5 minutes after anesthesia induction
|
Static compliance = exhaled tidal volume / (plateau pressure - PEEP), Dynamic compliance = Exhaled tidal volume / (PIP - PEEP)
|
5 minutes after anesthesia induction
|
|
Respiratory compliance (Static, Dynamic)
Time Frame: 60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
Static compliance = exhaled tidal volume / (plateau pressure - PEEP), Dynamic compliance = Exhaled tidal volume / (PIP - PEEP)
|
60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
Respiratory compliance (Static, Dynamic)
Time Frame: 120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
Static compliance = exhaled tidal volume / (plateau pressure - PEEP), Dynamic compliance = Exhaled tidal volume / (PIP - PEEP)
|
120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
oxygen index
Time Frame: 5 minutes after anesthesia induction
|
oxygen index calculated by PaO2/inspired oxygen fraction
|
5 minutes after anesthesia induction
|
|
oxygen index
Time Frame: 60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
oxygen index calculated by PaO2/inspired oxygen fraction
|
60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
oxygen index
Time Frame: 120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
oxygen index calculated by PaO2/inspired oxygen fraction
|
120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
Alveolar-arterial oxygen difference
Time Frame: 5 minutes after anesthesia induction
|
5 minutes after anesthesia induction
|
|
|
Alveolar-arterial oxygen difference
Time Frame: 60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
60 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
|
|
Alveolar-arterial oxygen difference
Time Frame: 120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
120 min after the initiation of pneumoperitoneum with steep Trendelenburg positioning
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kim MS, Kim NY, Lee KY, Choi YD, Hong JH, Bai SJ. The impact of two different inspiratory to expiratory ratios (1:1 and 1:2) on respiratory mechanics and oxygenation during volume-controlled ventilation in robot-assisted laparoscopic radical prostatectomy: a randomized controlled trial. Can J Anaesth. 2015 Sep;62(9):979-87. doi: 10.1007/s12630-015-0383-2. Epub 2015 Apr 14.
- Gainsburg DM. Anesthetic concerns for robotic-assisted laparoscopic radical prostatectomy. Minerva Anestesiol. 2012 May;78(5):596-604. Epub 2012 Mar 13.
- De Carlo F, Celestino F, Verri C, Masedu F, Liberati E, Di Stasi SM. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. Urol Int. 2014;93(4):373-83. doi: 10.1159/000366008. Epub 2014 Sep 23.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2016
Primary Completion (Actual)
February 1, 2017
Study Completion (Actual)
April 1, 2017
Study Registration Dates
First Submitted
November 13, 2016
First Submitted That Met QC Criteria
November 15, 2016
First Posted (Estimate)
November 17, 2016
Study Record Updates
Last Update Posted (Actual)
March 14, 2019
Last Update Submitted That Met QC Criteria
March 12, 2019
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1609-102-793
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostatic Neoplasm
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,ProstaticUnited States
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer CenterCompletedProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Neoplasm of Uncertain BehaviorUnited States
-
Rio de Janeiro State UniversityCompletedProstatic Cancer | Prostatic NeoplasmBrazil
-
Centre Hospitalier Universitaire de BesanconRecruiting
-
Fondazione del Piemonte per l'OncologiaCompleted
-
AbbottCompletedProstatic NeoplasmBelgium, Luxembourg
-
Mayo ClinicCompletedProstatic NeoplasmUnited States
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted
-
Sismanoglio General HospitalNational and Kapodistrian University of AthensCompletedProstatic NeoplasmGreece
-
AHS Cancer Control AlbertaCross Cancer InstituteCompleted
Clinical Trials on Adjustment of Mechanical Ventilator Inspiratory to expiratory time ratio (1:2 to 1:1)
-
Başakşehir Çam & Sakura City HospitalCompletedAcute Respiratory Distress Syndrome (ARDS) | Ventilated Patient in Intensive CareTurkey
-
Yonsei UniversityCompletedGeneral Anesthesia Using Endotracheal IntubationKorea, Republic of
-
General Hospital of Ningxia Medical UniversityCompleted
-
Kastamonu UniversityCompleted
-
Samsung Medical CenterCompletedLung Cancer | One Lung Ventilation | Gas Exchange | Inverse-ratio VentilationKorea, Republic of
-
Scholastica Fina Aryu PuspasariSTIKes Panti Rapih YogyakartaNot yet recruitingChronic Obstructive Pulmonary Disease (COPD)
-
South Valley UniversityNot yet recruitingVentilator-Induced Diaphragmatic Dysfunction
-
Institut BergoniéSanofiWithdrawnCarcinoma, Non-Small-Cell LungFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingIntrauterine Growth Restriction | Fetal Growth Restriction (FGR)France
-
Santé CannabisTetra Bio-PharmaTerminated